Expand HELP Menu
HELP MENU

HELP Stock Posts


Unusual Option Volume

HELP Helus Pharma5.79+0.02 (+0.4%)

Helus Pharma trades 3,692 contracts. News: Helus Pharma Strengthens Scientific Advisory Board with Addition of Dr. Robert Langer and Dr. Stephen Brannan
View Details...
Unusual Option Volume

HELP Helus Pharma5.34+0.41 (+8.3%)

Helus Pharma trades 2,330 contracts. The highest volume is in the 15-May-26 7.5 calls, which is 40.4% above the current price.
View Details...
Unusual Option Volume

HELP Helus Pharma5.34-0.27 (-4.8%)

Helus Pharma trades 2,513 contracts.
View Details...
Unusual Option Volume

HELP Helus Pharma5.70+0.20 (+3.6%)

Helus Pharma trades 2,620 contracts. News: Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions
View Details...
Unusual Option Volume

HELP Helus Pharma5.47-3.06 (-35.9%)

Helus Pharma trades 2,745 contracts. The company has the following event: Topline Results Presentation for Phase 2 Signal Detection Study of HLP004 in Generalized Anxiety Disorder on Mar 5, 2026. News: Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder
View Details...
HELP #HelusPharma stock declines -17.9% in premarket,

Premarket Decliner

HELP Helus Pharma8.53+0.63+8.0%

Premarket:7.00-1.53 (-17.9%)

Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder

Globe NewswireThu, 5-Mar 7:30 AM
Load Earlier Posts
Market Data Delayed 15 Minutes